Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by ext...
Main Authors: | Jayne, DR, Rasmussen, N |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
1997
|
פריטים דומים
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
מאת: Mukhtyar, C, et al.
יצא לאור: (2006) -
Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
מאת: Rohini Handa
יצא לאור: (2018-01-01) -
Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
מאת: John Chuan Nguyen Tran, et al.
יצא לאור: (2022-12-01) -
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
מאת: Flossmann, O, et al.
יצא לאור: (2006) -
Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
מאת: Brendan L. Thoms, et al.
יצא לאור: (2021-07-01)